599
Participants
Start Date
July 31, 2011
Primary Completion Date
August 31, 2012
Palonosetron Hydrochloride
0.25 mg IV\*1 dose on day 1, 30 minutes prior to the administration of the major chemotherapeutic agent.
Palonosetron Hydrochloride
0.25mg IV\*3 doses on days 1,3 and 5,30 minutes prior to the administration of the major chemotherapeutic agent.
Anhui Provincial Hospital, Hefei
Chinese Academy of Medical Sciences Cancer Hospital, Beijing
Chinese PLA 301 Hospital, Beijing
Chinese PLA 307 Hospital, Beijing
Chinese PLA Navy General Hospital, Beijing
Fuzhou General Hospital of Nanjing Military Command, Fuzhou
Guangxi Cancer Hospital, Nanning
The Second Xiangya Hospital of Central South University, Changsha
The First People's Hospital of Changzhou, Changzhou
Nanjing General Hospital of Nanjing Military Command, Nanjing
The First Affiliated Hospital of Soochow University, Suzhou
The Fourth People's Hospital of Wuxi, Wuxi
Shandong Cancer Hospital, Jinan
Shandong Provincial Hospital, Jinan
The Affiliated Hospital of Medical College Qingdao University, Qingdao
Shanghai Changzheng Hospital, Shanghai
Shanghai Xinhua Hospital, Shanghai
Tangdu Hospital of Fourth Military Medical University, Xian
JiangSu Chia-Tai Tianqin Pharmacy Co.Ltd
UNKNOWN
Shanghai Changzheng Hospital
OTHER